Answers are grounded in this paper and cite their sources.
'Lipodystrophy syndrome' in the setting of HIV infection has come to encompass a collection of morphological and metabolic abnormalities linked with the use of antiretroviral therapy and other risk factors. We review the clinical literature on this subject as it has evolved historically, taking pertinent methodological issues into account.
No takes yet. Share an insight, caveat, or question.
John et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: